JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, cilt.32, sa.5, 2010 (SCI-Expanded)
Background: L-asparaginase is effective in the treatment of malignant diseases, but it has been associated with hypersensitivity reactions in 5% to 45% of the patients.